Key result
CMR detects LGE in ~57% of female DMD carriers, frequently in inferolateral segments.
Why the study?
Cardiac involvement in female DMD carriers is difficult to differentiate non-invasively from other heart diseases due to possible LV wall motion abnormalities without muscle weakness.
Does gadolinium-enhanced CMR detect myocardial damage in female carriers of Duchenne muscular dystrophy?
Observational (n=7)
No
Does gadolinium-enhanced CMR detect myocardial damage in female carriers of Duchenne muscular dystrophy?
CMR with late gadolinium enhancement is a useful modality for detecting early cardiac involvement, specifically subepicardial LGE in inferolateral segments, in female carriers of Duchenne muscular dystrophy.
Answers are grounded in this paper and cite their sources.
Gadolinium-enhanced CMR may detect early myocardial damage in female DMD carriers; leaves open its screening role pending larger studies.
BACKGROUND: Cardiac involvement is a recognised complication in female carriers of Duchenne muscular dystrophy (DMD). Since segmental or global left ventricle (LV) wall motion abnormalities in DMD carriers can arise even without apparent muscle weakness, it is difficult to differentiate cardiac involvement of a DMD carrier from other heart diseases in a non-invasive manner. Cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) enables assessment of regional wall motion abnormality and myocardial damage with high spatial resolution. OBJECTIVE: To assess the utility of CMR for detection of myocardial damage in female carriers of DMD. METHODS AND RESULTS: Gadolinium-enhanced CMR was performed in seven female DMD carriers. Physical examination, electrocardiography, chest radiograph, measurements of total creatinine kinase and brain natriuretic peptide levels, and two-dimensional echocardiography were also performed. Four (57%) of the seven carriers had LGE, and LGE was frequently observed at the subepicardial layer in the inferolateral segment. Two carriers had a focal LGE at the LV inferolateral wall without LV dilation or wall motion abnormalities. CONCLUSION: CMR findings of DMD carriers were characterised by subepicardial LGE, which was localised at inferolateral segments. CMR may be a useful modality for detecting cardiac involvement in DMD carriers.
No takes yet. Share an insight, caveat, or question.
Iwase et al. (2010) conducted an observational in Duchenne muscular dystrophy (DMD) carriers (n=7). Cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) vs. Two-dimensional echocardiography was evaluated on Detection of myocardial damage via late gadolinium enhancement (LGE). Cardiac magnetic resonance detected late gadolinium enhancement in 57% (4 of 7) of female Duchenne muscular dystrophy carriers, frequently localizing to the subepicardial layer in the inferolateral segment even without left ventricular dilation.
Synapse has enriched 10 related papers. Consider them for comparative context: